Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Chinese Stocks To Watch Today - October 23rd

Diageo logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • MarketBeat identified five Chinese-related stocks with the highest recent dollar trading volume: Diageo (DEO), UP Fintech (TIGR), Regencell Bioscience (RGC), China SXT Pharmaceuticals (SXTC), and Universe Pharmaceuticals (UPC).
  • The companies span multiple sectors, including alcoholic beverages, online brokerage services, and traditional Chinese medicine and pharmaceutical products.
  • Investors seeking exposure to these stocks should consider China-related regulatory, political, currency, and geopolitical risks, in addition to company-specific factors.
  • Want to know the moment analysts change their view on Diageo? Get MarketBeat All Access for $149 a year and keep that rate for life.

Diageo, UP Fintech, Regencell Bioscience, China SXT Pharmaceuticals, and Universe Pharmaceuticals are the five Chinese stocks to watch today, according to MarketBeat's stock screener tool. “Chinese stocks” refers to shares of companies based in China or substantially connected to the Chinese economy, traded on mainland Chinese exchanges or international markets such as Hong Kong and the United States. For investors, these stocks may offer exposure to China’s economic growth but can also involve unique regulatory, political, currency, and geopolitical risks. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Read Our Latest Research Report on TIGR

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Read Our Latest Research Report on RGC

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Read Our Latest Research Report on SXTC

Universe Pharmaceuticals (UPC)

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.

Read Our Latest Research Report on UPC

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Diageo Right Now?

Before you consider Diageo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diageo wasn't on the list.

While Diageo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines